Matthew Notarianni | executive |
Joseph Capper | executive |
Douglas Rice | executive |
Brooks O'Neil | analyst |
Anthony Petrone | analyst |
Carl Byrnes | analyst |
John Vandermosten | analyst |
Good afternoon, and thank you for standing by. Welcome to the MiMedx First Quarter 2024 Operating and Financial Results Conference Call. [Operator Instructions].
As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Mr.